Rational Design of Angiotensin‐I‐Converting Enzyme Inhibitory Peptides by Integrating in silico Modeling and an in vitro Assay

No abstract is available for this paper.

• Publication year

  2013

• Venue

  ChemMedChem

• Publication date

  2013-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.201300132PMID 23740817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food

  2012cited by this paper
• Proteome-Wide Inference of Src Homology 3 Domain-Binding Peptides

  2012cited by this paper
• Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis

  2012cited by this paper
• Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides

  2012cited by this paper
• Antihypertensive peptides from food proteins: a review.

  2012cited by this paper
• Why QSAR fails: an empirical evaluation using conventional computational approach.

  2011cited by this paper
• Structure-based prediction of protein–protein binding affinity with consideration of allosteric effect

  2011cited by this paper
• Predicting the Binding Affinity of Epitope‐Peptides with HLA‐A*0201 by Encoding Atom‐Pair Non‐covalent Interaction Information between Receptor and Ligands

  2010cited by this paper
• The structural basis of peptide-protein binding strategies.

  2010cited by this paper
• Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands

  2010cited by this paper
• Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food.

  2009cited by this paper
• Rational drug design.

  2009cited by this paper
• Improved prediction of protein side‐chain conformations with SCWRL4

  2009cited by this paper
• Three‐dimensional holograph vector of atomic interaction field (3D‐HoVAIF): a novel rotation–translation invariant 3D structure descriptor and its applications to peptides

  2007cited by this paper
• Full regularization path for sparse principal component analysis

  2007cited by this paper
• Modelling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides

  2007cited by this paper
• ACE-inhibitory and radical-scavenging activity of peptides derived from beta-lactoglobulin f(19-25). Interactions with ascorbic acid.

  2007cited by this paper
• Computational Analysis and Prediction of the Binding Motif and Protein Interacting Partners of the Abl SH3 Domain

  2006cited by this paper
• The ACE and I: how ACE inhibitors came to be

  2006cited by this paper
• Antihypertensive Effect of Angiotensin I-Converting Enzyme Inhibitory Peptides from a Sesame Protein Hydrolysate in Spontaneously Hypertensive Rats

  2006cited by this paper
• Worldwide epidemic of hypertension.

  2006cited by this paper
• Structural Requirements of Angiotensin I‐Converting Enzyme Inhibitory Peptides: Quantitative Structure‐Activity Relationship Modeling of Peptides Containing 4‐10 Amino Acid Residues

  2006cited by this paper
• Cooperation Prevails When Individuals Adjust Their Social Ties

  2006cited by this paper
• Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max).

  2006cited by this paper
• Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides.

  2006cited by this paper
• Analysis of novel angiotensin‐I‐converting enzyme inhibitory peptides from protease‐hydrolyzed marine shrimp Acetes chinensis

  2006cited by this paper
• Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.

  2005cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations

  2003cited by this paper
• Angiotensin-I-converting enzyme and its relatives

  2003cited by this paper
• Beware of q2!

  2002cited by this paper
• Identification of angiotensin I-converting enzyme inhibitory peptides derived from the peptic digest of soybean protein

  2002cited by this paper
• Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.

  2002cited by this paper
• PLS-regression: a basic tool of chemometrics

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Isolation of Acein‐2, a novel angiotensin‐I‐converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma

  2000cited by this paper
• Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins

  2000cited by this paper
• Use of MM‐PB/SA in estimating the free energies of proteins: Application to native, intermediates, and unfolded villin headpiece

  2000cited by this paper
• Alanine-stretch scanning mutagenesis: a simple and efficient method to probe protein structure and function.

  1997cited by this paper
• Isolation from alpha-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.

  1996cited by this paper
• Current Drug Treatment and Treatment Patterns with Antihypertensive Drugs

  1996cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

  1994cited by this paper
• Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle.

  1994cited by this paper
• Genetic algorithms: principles of natural selection applied to computation.

  1993cited by this paper
• Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

  1993cited by this paper
• Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito.

  1992cited by this paper
• Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various β-caseins

  1990cited by this paper
• Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various beta-caseins.

  1990cited by this paper
• Antihypertensive Drug Side Effects in the Hypertension Detection and Follow‐up Program

  1988cited by this paper
• Peptide quantitative structure-activity relationships, a multivariate approach.

  1987cited by this paper
• The broad substrate specificity of human angiotensin I converting enzyme.

  1987cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper
• Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.

  1971cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper
• proteins STRUCTURE O FUNCTION O BIOINFORMATICS Improved prediction of protein side-chain conformations with SCWRL4

  year unknowncited by this paper

• Exploiting the chemical diversity space of phosphopeptide binding to nasopharyngeal carcinoma PLK1 PBD domain with unnatural amino acid building blocks by using QSAR-based genetic optimization

  2024cites this paper
• Facile and Scalable Synthesis of Tripeptides with a Pro‐Pro Scaffold at C‐end: A TAG Approach

  2024cites this paper
• PepQSAR: a comprehensive data source and information platform for peptide quantitative structure–activity relationships

  2022cites this paper
• Integrated In Silico-In Vitro Molecular Modeling and Design of Halogenated Phenylalanine-containing Antihypertensive Peptide Inhibitors with Halogen Bonds to Target Human Angiotensin-I-Converting Enzyme

  2022cites this paper
• Rational truncation, mutation, and halogenation of bradykinin neuropeptides as potent ACEII inhibitors by integrating molecular dynamics simulations, quantum mechanics calculations, and in vitro assays

  2022cites this paper
• Molecular selectivity design of mitogen-inducible gene-derived phosphopeptides between oncogenic HER kinases.

  2020cites this paper
• Characterization of Angiotensin-Converting Enzyme Inhibitory Activity of X-Hyp-Gly-Type Tripeptides: Importance of Collagen-Specific Prolyl Hydroxylation.

  2018cites this paper
• Machine learning‐based genetic evolution of antitumor proteins containing unnatural amino acids by integrating chemometric modeling and cytotoxicity analysis

  2018cites this paper
• Transepithelial transport across Caco-2 cell monolayers of angiotensin converting enzyme (ACE) inhibitory peptides derived from simulated in vitro gastrointestinal digestion of cooked chicken muscles.

  2018cites this paper
• Structure-based rational design of peptide inhibitors to disrupt the recognition and interaction between hepatitis B virus large envelope protein and human hepatocyte receptor γ2-adaptin

  2017cites this paper
• Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents.

  2017cites this paper
• Computational design of peptide ligands to target the intermolecular interaction between viral envelope protein and pediatric receptor

  2017cites this paper
• Molecular design and genetic optimization of antimicrobial peptides containing unnatural amino acids against antibiotic‐resistant bacterial infections

  2016cites this paper
• Bioactive peptides derived from in vitro gastrointestinal digestion of cooked chicken meat

  2016cites this paper
• Rational Evolution of Antimicrobial Peptides Containing Unnatural Amino Acids to Combat Burn Wound Infections

  2016cites this paper
• Targeting Yes‐associated Protein with Evolved Peptide Aptamers to Disrupt TGF‐β Signaling Pathway: Therapeutic Implication for Bone Tumor

  2015cites this paper
• Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis

  2015cites this paper
• Rational design of YAP WW1 domain‐binding peptides to target TGFβ/BMP/Smad–YAP interaction in heterotopic ossification

  2015cites this paper
• Potent inhibition of TGF-β signaling pathway regulator Abl: potential therapeutics for hepatic fibrosis

  2015cites this paper
• Structure-based design and optimization of antihypertensive peptides to obtain high inhibitory potency against both renin and angiotensin I-converting enzyme

  2015cites this paper
• Evolution of High-Affinity Peptide Probes to Detect the SH3 Domain of Cancer Biomarker BCR–ABL

  2014cites this paper
• Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE‐Inhibitory Peptides

  2014cites this paper
• Design of p53-derived peptides with cytotoxicity on breast cancer

  2014cites this paper